Patents by Inventor Dapeng Yao

Dapeng Yao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12352664
    Abstract: A method and a system for diagnosing high-enthalpy shock tunnel flow field parameters are provided. In the method, the parameters of the reservoir at the end of shock tunnel and nozzle free flow are measured by using a contact measurement technology and a non-contact spectrum measurement technology to diagnose the high-enthalpy shock tunnel flow field. With the method, not only flow field temperature, pressure, component category and component concentration, but also non-equilibrium state information of the flow field and the effective wind tunnel working time can be obtained.
    Type: Grant
    Filed: December 30, 2021
    Date of Patent: July 8, 2025
    Assignee: China Academy of Aerospace Aerodynamics
    Inventors: Junmou Shen, Meixiao Hu, Jian Gong, Zhongjie Shao, Wei Chen, Xiangyu Yi, Hongbo Lu, Huazhen Song, Shuai Wen, Dapeng Yao, Jian Pang, Feng Ji
  • Publication number: 20240310240
    Abstract: A method and a system for diagnosing high-enthalpy shock tunnel flow field parameters are provided. In the method, the parameters of the reservoir at the end of shock tunnel and nozzle free flow are measured by using a contact measurement technology and a non-contact spectrum measurement technology to diagnose the high-enthalpy shock tunnel flow field. With the method, not only flow field temperature, pressure, component category and component concentration, but also non-equilibrium state information of the flow field and the effective wind tunnel working time can be obtained.
    Type: Application
    Filed: December 30, 2021
    Publication date: September 19, 2024
    Applicant: China Academy of Aerospace Aerodynamics
    Inventors: Junmou Shen, Meixiao Hu, Jian Gong, Zhongije Shao, Wei Chen, Xiangyu Yi, Hongbo Lu, Huazhen Song, Shuai Wen, Dapeng Yao, Jian Pang, Feng Ji
  • Patent number: 9217033
    Abstract: The present disclosure provides isolated monoclonal antibodies, particularly human monoclonal antibodies that specifically bind to Glypican-3 with high affinity. Nucleic acid molecules encoding Glypican-3 antibodies, expression vectors, host cells and methods for expressing the Glypican-3 antibodies are also provided. Immunoconjugates, bispecific molecules and pharmaceutical compositions comprising the Glypican-3 antibodies are also provided. Methods for detecting Glypican-3, as well as methods for treating various Glypican-3-related conditions, including hepatocellular cancer, are disclosed.
    Type: Grant
    Filed: February 10, 2014
    Date of Patent: December 22, 2015
    Assignee: E. R. SQUIBB & SONS, L.L.C.
    Inventors: Jonathan Alexander Terrett, Li-Sheng Lu, Haichun Huang, Dapeng Yao, Chin Pan, Heidi N. LeBlanc, Tim W. Sproul, Mark Yamanaka
  • Publication number: 20140186892
    Abstract: The present disclosure provides isolated monoclonal antibodies, particularly human monoclonal antibodies that specifically bind to Glypican-3 with high affinity. Nucleic acid molecules encoding Glypican-3 antibodies, expression vectors, host cells and methods for expressing the Glypican-3 antibodies are also provided. Immunoconjugates, bispecific molecules and pharmaceutical compositions comprising the Glypican-3 antibodies are also provided. Methods for detecting Glypican-3, as well as methods for treating various Glypican-3-related conditions, including hepatocellular cancer, are disclosed.
    Type: Application
    Filed: February 10, 2014
    Publication date: July 3, 2014
    Inventors: Jonathan Alexander Terrett, Li-Sheng Lu, Haichun Huang, Dapeng Yao, Chin Pan, Heidi N. LeBlanc, Tim W. Sproul, Mark Yamanaka
  • Patent number: 8680247
    Abstract: The present disclosure provides isolated monoclonal antibodies, particularly human monoclonal antibodies that specifically bind to Glypican-3 with high affinity. Nucleic acid molecules encoding Glypican-3 antibodies, expression vectors, host cells and methods for expressing the Glypican-3 antibodies are also provided. Immunoconjugates, bispecific molecules and pharmaceutical compositions comprising the Glypican-3 antibodies are also provided. Methods for detecting Glypican-3, as well as methods for treating various Glypican-3-related conditions, including hepatocellular cancer, are disclosed.
    Type: Grant
    Filed: July 17, 2008
    Date of Patent: March 25, 2014
    Assignee: Medarex, L.L.C.
    Inventors: Jonathan Alexander Terrett, Li-Sheng Lu, Haichun Huang, Dapeng Yao, Chin Pan, Heidi Leblanc, Timothy Sproul, Mark Yamanaka
  • Publication number: 20100209432
    Abstract: The present disclosure provides isolated monoclonal antibodies, particularly human monoclonal antibodies that specifically bind to Glypican-3 with high affinity. Nucleic acid molecules encoding Glypican-3 antibodies, expression vectors, host cells and methods for expressing the Glypican-3 antibodies are also provided. Immunoconjugates, bispecific molecules and pharmaceutical compositions comprising the Glypican-3 antibodies are also provided. Methods for detecting Glypican-3, as well as methods for treating various Glypican-3-related conditions, including hepatocellular cancer, are disclosed.
    Type: Application
    Filed: July 17, 2008
    Publication date: August 19, 2010
    Applicant: MEDAREX, INC.
    Inventors: Jonathan Alexander Terrette, Li-sheng Lu, Haichun Huang, Dapeng Yao, Chin Pan, Heidi Leblanc, Timothy Sproul, Mark Yamanaka